Cargando…
Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses
Cryptosporidium infects gastrointestinal epithelium and is a leading cause of infectious diarrhea and diarrheal-related death in children worldwide. There are no vaccines and no fully effective therapy available for the infection. Type II and III interferon (IFN) responses are important determinants...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020566/ https://www.ncbi.nlm.nih.gov/pubmed/36928642 http://dx.doi.org/10.1038/s41467-023-37129-0 |
_version_ | 1784908287615959040 |
---|---|
author | Deng, Silu He, Wei Gong, Ai-Yu Li, Min Wang, Yang Xia, Zijie Zhang, Xin-Tiang Huang Pacheco, Andrew S. Naqib, Ankur Jenkins, Mark Swanson, Patrick C. Drescher, Kristen M. Strauss-Soukup, Juliane K. Belshan, Michael Chen, Xian-Ming |
author_facet | Deng, Silu He, Wei Gong, Ai-Yu Li, Min Wang, Yang Xia, Zijie Zhang, Xin-Tiang Huang Pacheco, Andrew S. Naqib, Ankur Jenkins, Mark Swanson, Patrick C. Drescher, Kristen M. Strauss-Soukup, Juliane K. Belshan, Michael Chen, Xian-Ming |
author_sort | Deng, Silu |
collection | PubMed |
description | Cryptosporidium infects gastrointestinal epithelium and is a leading cause of infectious diarrhea and diarrheal-related death in children worldwide. There are no vaccines and no fully effective therapy available for the infection. Type II and III interferon (IFN) responses are important determinants of susceptibility to infection but the role for type I IFN response remains obscure. Cryptosporidium parvum virus 1 (CSpV1) is a double-stranded RNA (dsRNA) virus harbored by Cryptosporidium spp. Here we show that intestinal epithelial conditional Ifnar1(−/−) mice (deficient in type I IFN receptor) are resistant to C. parvum infection. CSpV1-dsRNAs are delivered into host cells and trigger type I IFN response in infected cells. Whereas C. parvum infection attenuates epithelial response to IFN-γ, loss of type I IFN signaling or inhibition of CSpV1-dsRNA delivery can restore IFN-γ-mediated protective response. Our findings demonstrate that type I IFN signaling in intestinal epithelial cells is detrimental to intestinal anti-C. parvum defense and Cryptosporidium uses CSpV1 to activate type I IFN signaling to evade epithelial antiparasitic response. |
format | Online Article Text |
id | pubmed-10020566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-100205662023-03-18 Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses Deng, Silu He, Wei Gong, Ai-Yu Li, Min Wang, Yang Xia, Zijie Zhang, Xin-Tiang Huang Pacheco, Andrew S. Naqib, Ankur Jenkins, Mark Swanson, Patrick C. Drescher, Kristen M. Strauss-Soukup, Juliane K. Belshan, Michael Chen, Xian-Ming Nat Commun Article Cryptosporidium infects gastrointestinal epithelium and is a leading cause of infectious diarrhea and diarrheal-related death in children worldwide. There are no vaccines and no fully effective therapy available for the infection. Type II and III interferon (IFN) responses are important determinants of susceptibility to infection but the role for type I IFN response remains obscure. Cryptosporidium parvum virus 1 (CSpV1) is a double-stranded RNA (dsRNA) virus harbored by Cryptosporidium spp. Here we show that intestinal epithelial conditional Ifnar1(−/−) mice (deficient in type I IFN receptor) are resistant to C. parvum infection. CSpV1-dsRNAs are delivered into host cells and trigger type I IFN response in infected cells. Whereas C. parvum infection attenuates epithelial response to IFN-γ, loss of type I IFN signaling or inhibition of CSpV1-dsRNA delivery can restore IFN-γ-mediated protective response. Our findings demonstrate that type I IFN signaling in intestinal epithelial cells is detrimental to intestinal anti-C. parvum defense and Cryptosporidium uses CSpV1 to activate type I IFN signaling to evade epithelial antiparasitic response. Nature Publishing Group UK 2023-03-16 /pmc/articles/PMC10020566/ /pubmed/36928642 http://dx.doi.org/10.1038/s41467-023-37129-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Deng, Silu He, Wei Gong, Ai-Yu Li, Min Wang, Yang Xia, Zijie Zhang, Xin-Tiang Huang Pacheco, Andrew S. Naqib, Ankur Jenkins, Mark Swanson, Patrick C. Drescher, Kristen M. Strauss-Soukup, Juliane K. Belshan, Michael Chen, Xian-Ming Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses |
title | Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses |
title_full | Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses |
title_fullStr | Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses |
title_full_unstemmed | Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses |
title_short | Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses |
title_sort | cryptosporidium uses cspv1 to activate host type i interferon and attenuate antiparasitic defenses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020566/ https://www.ncbi.nlm.nih.gov/pubmed/36928642 http://dx.doi.org/10.1038/s41467-023-37129-0 |
work_keys_str_mv | AT dengsilu cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT hewei cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT gongaiyu cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT limin cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT wangyang cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT xiazijie cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT zhangxintiang cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT huangpachecoandrews cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT naqibankur cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT jenkinsmark cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT swansonpatrickc cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT drescherkristenm cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT strausssoukupjulianek cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT belshanmichael cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses AT chenxianming cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses |